This session provides a comprehensive, case-based overview of the contemporary management of Type B aortic dissections, bringing together international perspectives, real-world data, and the latest clinical evidence. Through a series of clinical cases from Europe, Asia, and New Zealand, experts will explore decision-making in acute Type B dissections, highlighting regional differences in practice, technical challenges, and treatment strategies. Special focus will be placed on the role of endovascular treatment in patients with genetic aortic disorders, addressing indications, limitations, and long-term considerations. The session will also present real-world data from China on aortic treatment in patients with genetic disorders, offering valuable insights beyond controlled trial settings. Finally, attendees will receive key updates from major dissection trials, including the SUNDAY trial, with discussion on how emerging evidence may influence future clinical practice. This session is designed to be highly practical and interactive, providing vascular specialists with actionable insights for managing complex Type B aortic dissection cases across diverse patient populations.
